Results 161 to 170 of about 77,218 (232)

Use of dupilumab to manage a grade 3 cutaneous adverse effect from enfortumab vedotin/pembrolizumab treatment in a patient with metastatic urothelial carcinoma

open access: yesJAAD Case Reports
Maura C. Gillis, BA   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy